Retraction Note: CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s13048-019-0593-2.
Main Authors: | Zhi-Ying Qi, Fang Wang, Ying-Ying Yue, Xue-Wang Guo, Rui-Meng Guo, Hong-Lin Li, Yan-Ying Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-08-01
|
Series: | Journal of Ovarian Research |
Online Access: | https://doi.org/10.1186/s13048-023-01267-2 |
Similar Items
-
RETRACTED ARTICLE: CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo
by: Zhi-Ying Qi, et al.
Published: (2019-11-01) -
Retraction Note: Systematic analyses reveal long non-coding RNA (PTAF)-mediated promotion of EMT and invasion-metastasis in serous ovarian cancer
by: Haihai Liang, et al.
Published: (2023-04-01) -
Characterization of candidate factors associated with the metastasis and progression of high-grade serous ovarian cancer
by: Huiping Liu, et al.
Published: (2023-12-01) -
SOCS7/HuR/FOXM1 signaling axis inhibited high-grade serous ovarian carcinoma progression
by: Yanhua Du, et al.
Published: (2022-05-01) -
Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer
by: Yifan Cheng, et al.
Published: (2024-04-01)